Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 121.41% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTCERENOME, INC.'s latest supported as-filed period reports revenue of $411,000, 70.4% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 121.41% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -1735.28% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -70.43% · CORE
Level · gp.fundamentals.operating_margin
Raw value -2203.65% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 1037.71% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 201.95% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Capital expenditure changed across a low base; Capex / revenue moved 12091 bp higher.
2 evidence-backed componentsOperating cash flow changed -23.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CNSY · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-387267SEC ↗10-QAug 14, 2026Period Jun 30, 20260001193125-26-352444SEC ↗8-KAug 14, 2026Period Aug 14, 20260001193125-26-352346SEC ↗8-KAug 4, 2026Period Aug 3, 20260001193125-26-332939SEC ↗4Jul 1, 2026Period Jul 1, 20260001193125-26-292654SEC ↗4Jul 1, 2026Period Jul 1, 20260001193125-26-292644SEC ↗4Jul 1, 2026Period Jul 1, 20260001193125-26-292643SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Free-cash-flow proxy changed -31.5% from the comparable as-filed period.
Operating income changed -488.9% from the comparable as-filed period.
Stock-based compensation changed +446.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -209300 basis points from the comparable as-filed period.
Revenue changed -70.4% from the comparable as-filed period.
Capex / revenue changed +12091 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-292642